Atlas Trials

Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients

Clinical trial NCT01214174 · TERMINATED

Trial details

NCT number
NCT01214174
Sponsor
ICON Bioscience Inc
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Ocular Inflammation
Start date
2010-10-01
Primary completion
2012-05-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.